Benitec Biopharma Inc
For the period ended Dec 31, 2023. Filed Feb 13, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Dec 31, 2023 · Filed Feb 13, 2024
BNTC$9.54+10.4%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Table of Contents
INDEX TO FORM 10-Q
| SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS | 1 | ||
|---|---|---|---|
| PART I-FINANCIAL INFORMATION | 2 | ||
| ITEM 1. | Financial Statements | 2 | |
| Consolidated Balance Sheets as of December 31, 2023 (Unaudited) and June 30, 2023 | 2 | ||
| Consolidated Statements of Operations and Comprehensive Loss for the Three and Six Months Ended December 31, 2023 and 2022 (Unaudited) | 3 | ||
| Consolidated Statements of Stockholders’ Equity for the Six Months Ended December 31, 2023 and 2022 (Unaudited) | 4 | ||
| Consolidated Statements of Cash Flows for the Six Months Ended December 31, 2023 and 2022 (Unaudited) | 5 | ||
| Notes to Consolidated Financial Statements (Unaudited) | 6 | ||
| ITEM 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 15 | |
| ITEM 3. | Quantitative and Qualitative Disclosures About Market Risk | 54 | |
| ITEM 4. | Controls and Procedures | 54 | |
| PART II-OTHER INFORMATION | |||
| ITEM 1. | Legal Proceedings | 55 | |
| ITEM 1A. | Risk Factors | 55 | |
| ITEM 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 55 | |
| ITEM 3. | Defaults Upon Senior Securities | 55 | |
| ITEM 4. | Mine Safety Disclosures | 55 | |
| ITEM 5. | Other Information | 55 | |
| ITEM 6. | Exhibits | 55 | |
| SIGNATURES | 56 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.